Milwaukee-area banks plan new branches – and a closure
Three banks with locations in southeast Wisconsin could add new offices.
4 of Portland’s best-known developers on revitalizing downtown
Vanessa Sturgeon, Ernesto Fonseca, Homer Williams and Barry Cain discuss Portland's top issues.
Dallas firm banking on opportunities with launch of cost-segregation business
Matt Rader has been charged with launching BBG's cost-segregation service, a fresh opportunity levied at existing demand. He spoke more about the goals for the new business line and what's ahead for the firm in this interview with the Dallas Business Journal.
Wieland to leave Massport for National Grid executive role
Wieland has led the quasi-public agency since 2019. Her tenure at Massport has been dominated by the dramatic drop-off in travel to and from Logan International Airport during the pandemic and the continuing recovery since then.
Cook Out’s spinoff taco restaurant headed to Charlotte, permit shows
Cook Out's spinoff taco concept appears headed to Charlotte — but little is known about the brand.
Breaking: Owner of Moses Rose’s Hideout settles with city to hand over downtown property
The settlement amount was undisclosed.
What we learned from Molson Coors earnings
Chicago-based Molson Coors Beverage Co. reported its strongest financial quarter since 2005 with strength in the company's two core beer brands of Miller Lite and Coors Light.
Doctor and salon owner see potential in the next wellness trend: IV treatments
A doctor and a salon owner are betting on the future of IV therapies as part of their next venture.
Dr. Jackcy Jacob and Amanda O'Hearn, owner of Jean Paul Spa and Salon, have taken over the business Reviva Wellness along with their husbands, and are looking to grow.
Reviva offers IV therapies, NAD+ IV therapy (said to help cellular function as people age), rehydration drips, leg compression therapy, light therapy, external shock wave therapy, and more.
Alongside the rise of med spas, IV therapies…
Anheuser-Busch InBev reports Q2 net profit falls as US volume drops
Anheuser-Busch InBev reported a big drop in second-quarter net profit as its overall volumes fell, driven in part by a sales decline in North America.
Moderna ups forecast for fall Covid vaccines, but there’s one question mark
With the fall launch of its updated Covid-19 vaccine likely weeks away, Moderna Inc. is forecasting sales of $6 to $8 billion, up from the $5 billion it previously forecast. But there's one major unknown for the Cambridge biotech.